Identification of key genes by integrating DNA methylation and next-generation transcriptome sequencing for esophageal squamous cell carcinoma

Aberrant DNA methylation leads to abnormal gene expression, making it a significant regulator in the progression of cancer and leading to the requirement for integration of gene expression with DNA methylation. Here, we identified 120 genes demonstrating an inverse correlation between DNA methylation and mRNA expression in esophageal squamous cell carcinoma (ESCC). Sixteen key genes, such as SIX4, CRABP2, and EHD3, were obtained by filtering 10 datasets and verified in paired ESCC samples by qRT-PCR. 5-Aza-dC as a DNA methyltransferase (DNMT) inhibitor could recover their expression and inhibit clonal growth of cancer cells in seven ESCC cell lines. Furthermore, 11 of the 16 genes were correlated with OS (overall survival) and DFS (disease-free survival) in 125 ESCC patients. ChIP-Seq data and WGBS data showed that DNA methylation and H3K27ac histone modification of these key genes displayed inverse trends, suggesting that there was collaboration between DNA methylation and histone modification in ESCC. Our findings illustrate that the integrated multi-omics data (transcriptome and epigenomics) can accurately obtain potential prognostic biomarkers, which may provide important insight for the effective treatment of cancers.

[1]  E. Li,et al.  CNIT: a fast and accurate web tool for identifying protein-coding and long non-coding transcripts based on intrinsic sequence composition , 2019, Nucleic Acids Res..

[2]  M. Bebawy,et al.  Circulating tumor DNA - Current state of play and future perspectives. , 2018, Pharmacological research.

[3]  B. Berman,et al.  Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression , 2018, Nature Communications.

[4]  Y. Dor,et al.  Principles of DNA methylation and their implications for biology and medicine , 2018, The Lancet.

[5]  Guoying Miao,et al.  MFAP2 promotes epithelial–mesenchymal transition in gastric cancer cells by activating TGF-β/SMAD2/3 signaling pathway , 2018, OncoTargets and therapy.

[6]  Tim De Meyer,et al.  Analysis of DNA methylation in cancer: location revisited , 2018, Nature Reviews Clinical Oncology.

[7]  A. Topaloğlu,et al.  Molecular genetic studies in a case series of isolated hypoaldosteronism due to biosynthesis defects or aldosterone resistance , 2018, Clinical endocrinology.

[8]  E. Li,et al.  Protein-coding genes combined with long noncoding RNA as a novel transcriptome molecular staging model to predict the survival of patients with esophageal squamous cell carcinoma , 2018, Cancer communications.

[9]  W. Wang,et al.  SLC52A3 expression is activated by NF-κB p65/Rel-B and serves as a prognostic biomarker in esophageal cancer , 2018, Cellular and Molecular Life Sciences.

[10]  B. Berman,et al.  Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas , 2017, Gut.

[11]  Ming-Rong Wang,et al.  Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients. , 2017, Gastroenterology.

[12]  S. Ikeda,et al.  Genomic Alterations in Circulating Tumor DNA from Diverse Cancer Patients Identified by Next-Generation Sequencing. , 2017, Cancer research.

[13]  T. Ushijima,et al.  How to stomach an epigenetic insult: the gastric cancer epigenome , 2017, Nature Reviews Gastroenterology &Hepatology.

[14]  Michael Q. Zhang,et al.  Recurrently deregulated lncRNAs in hepatocellular carcinoma , 2017, Nature Communications.

[15]  E. Li,et al.  Integrative analyses of transcriptome sequencing identify novel functional lncRNAs in esophageal squamous cell carcinoma , 2017, Oncogenesis.

[16]  F. Setién,et al.  Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer , 2016, Proceedings of the National Academy of Sciences.

[17]  Jingting Jiang,et al.  Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[18]  Kongming Wu,et al.  The DACH/EYA/SIX gene network and its role in tumor initiation and progression , 2016, International journal of cancer.

[19]  William M. Grady,et al.  Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. , 2015, Gastroenterology.

[20]  W. Liang,et al.  Whole-genome bisulfite sequencing of cell-free DNA identifies signature associated with metastatic breast cancer , 2015, Clinical Epigenetics.

[21]  L. Kananen,et al.  Transcriptomic and epigenetic analyses reveal a gender difference in aging-associated inflammation: the Vitality 90+ study , 2015, AGE.

[22]  David Petersen,et al.  An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[23]  F. Costa,et al.  Epigenomes as therapeutic targets. , 2015, Pharmacology & therapeutics.

[24]  Manolis Kellis,et al.  Large-scale epigenome imputation improves data quality and disease variant enrichment , 2015, Nature Biotechnology.

[25]  Andrew E. Teschendorff,et al.  A systems-level integrative framework for genome-wide DNA methylation and gene expression data identifies differential gene expression modules under epigenetic control , 2014, Bioinform..

[26]  E. Li,et al.  Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinoma. , 2014, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[27]  Kevin Y. Yip,et al.  Whole-genome bisulfite sequencing of multiple individuals reveals complementary roles of promoter and gene body methylation in transcriptional regulation , 2014, Genome Biology.

[28]  F. Jardin.  Next generation sequencing and the management of diffuse large B-cell lymphoma: from whole exome analysis to targeted therapy. , 2014, Discovery medicine.

[29]  D. Boomsma,et al.  Epigenetic Variation in Monozygotic Twins: A Genome-Wide Analysis of DNA Methylation in Buccal Cells , 2014, Genes.

[30]  G. Batist,et al.  Ehd3, a regulator of vesicular trafficking, is silenced in gliomas and functions as a tumor suppressor by controlling cell cycle arrest and apoptosis. , 2014, Carcinogenesis.

[31]  Teng Jiang,et al.  Application of next-generation sequencing technologies in Neurology. , 2013, Annals of translational medicine.

[32]  G. Felsenfeld.  A brief history of epigenetics. , 2014, Cold Spring Harbor perspectives in biology.

[33]  J. Nielsen,et al.  Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics* , 2013, Molecular & Cellular Proteomics.

[34]  R. Young,et al.  Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.

[35]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[36]  Carlos Caldas,et al.  Analysis of circulating tumor DNA to monitor metastatic breast cancer. , 2013, The New England journal of medicine.

[37]  J. Luketich,et al.  Oesophageal carcinoma , 2013, The Lancet.

[38]  S. Lam,et al.  Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression , 2012, Genome research.

[39]  M. Esteller,et al.  Whole-genome bisulfite DNA sequencing of a DNMT3B mutant patient , 2012, Epigenetics.

[40]  Peter A. Jones.  Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.

[41]  E. Greer,et al.  Histone methylation: a dynamic mark in health, disease and inheritance , 2012, Nature Reviews Genetics.

[42]  K. Gunderson,et al.  High density DNA methylation array with single CpG site resolution. , 2011, Genomics.

[43]  C. Wu,et al.  Epigenetic activation of human kallikrein 13 enhances malignancy of lung adenocarcinoma by promoting N-cadherin expression and laminin degradation. , 2011, Biochemical and biophysical research communications.

[44]  Y. Miki,et al.  Down‐regulation of keratin 4 and keratin 13 expression in oral squamous cell carcinoma and epithelial dysplasia: a clue for histopathogenesis , 2011, Histopathology.

[45]  D. Sheff,et al.  EHD3 regulates early-endosome-to-Golgi transport and preserves Golgi morphology , 2009, Journal of Cell Science.

[46]  W. Chow,et al.  Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. , 2008, Journal of the National Cancer Institute.

[47]  K. Washington,et al.  DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett’s adenocarcinoma , 2008, Gut.

[48]  M. Suckow,et al.  Sulindac treatment alters collagen and matrilysin expression in adenomas of ApcMin/+ mice. , 2008, Carcinogenesis.

[49]  Peter D Siersema,et al.  Esophageal cancer. , 2008, Gastroenterology clinics of North America.

[50]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[51]  George Tseng,et al.  Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. , 2007, Cancer research.

[52]  L. Donato,et al.  Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling. , 2007, Cancer research.

[53]  J. Reitsma,et al.  Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  Towia A. Libermann,et al.  GADD45 Deregulation in Cancer: Frequently Methylated Tumor Suppressors and Potential Therapeutic Targets , 2005, Clinical Cancer Research.

[55]  L. Donato,et al.  Suppression of mammary carcinoma growth by retinoic acid: proapoptotic genes are targets for retinoic acid receptor and cellular retinoic acid-binding protein II signaling. , 2005, Cancer research.

[56]  C. Moskaluk,et al.  Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis. , 2005, Neoplasia.

[57]  E. Galperin,et al.  EHD3: A Protein That Resides in Recycling Tubular and Vesicular Membrane Structures and Interacts with EHD1 , 2002, Traffic.

[58]  A. Lindblom,et al.  Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. , 2001, Carcinogenesis.

[59]  W. Lau,et al.  Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. , 1999, Cancer research.